Strs Ohio grew its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 410,500 shares of the exchange traded fund’s stock after purchasing an additional 19,300 shares during the quarter. Strs Ohio owned about 0.63% of SPDR S&P Biotech ETF worth $52,433,000 as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. Prospect Financial Services LLC bought a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at $205,000. Essex Financial Services Inc. increased its position in SPDR S&P Biotech ETF by 6.0% during the 1st quarter. Essex Financial Services Inc. now owns 6,116 shares of the exchange traded fund’s stock worth $781,000 after buying an additional 345 shares during the period. Vertrix Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth $237,000. Financial Life Planners acquired a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth $27,000. Finally, Harbor Investment Advisory LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 4.8% during the first quarter. Harbor Investment Advisory LLC now owns 16,948 shares of the exchange traded fund’s stock worth $2,165,000 after buying an additional 783 shares in the last quarter.
SPDR S&P Biotech ETF Stock Performance
Shares of SPDR S&P Biotech ETF stock opened at $160.46 on Friday. The firm has a 50-day moving average of $136.95 and a 200-day moving average of $129.75. SPDR S&P Biotech ETF has a 52-week low of $83.02 and a 52-week high of $160.82. The stock has a market cap of $11.09 billion, a PE ratio of 11.47 and a beta of 0.81.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
